Hospital, Boston (Received 13 September 1947) After dl-thyroxine had been resolved by Harington in 1928, the activities of the d\ x=r eq-\ and l-isomers were assayed by Gaddum on tadpoles and rats and on humans by Salter, Lerman & Means. Gaddum [1930] demonstrated that the l-isomer is considerably more active than the d-form, the ratio of activity varying between 1\m=.\5 and 3 according to the dose used. On the other hand, Salter et al. [1935] , using patients with myxoedema as test objects, found that d-thyroxine is as active as l-thyroxine. They suggested three conditions that might explain these differences.
(1) The animals possessed intact thyroids which might trap newly administered iodine and which might fluctuate in activity. (2) The test material was administered to the animals in single massive doses instead of small daily doses which the patients with myxoedema received. In fact, in Gaddum's experiments, the ratio of activity approached unity as the dose administered became smaller. (3) The difference in species has to be con¬ sidered.
Some investigators have indicated that eZ-thyroxine has no activity. For example, Foster, Palmer & Leland [1936] found that Z-thyroxine has twice the metabolic activity of the ¿Z-mixture in guinea-pigs, and therefore inferred that the cZ-form has no activity whatever. More recently, Reineke & Turner [1943 , working with Z-thyroxine isolated from iodinated casein, came to the same conclusion.
Now that newer methods of isolating the isomers of thyroxine are available, the role of optical activity in thyroid physiology can be re-evaluated.
In recent work on the hydrogen peroxide oxidation of Z( + )-di-iodotyrosine, Harington & Pitt Rivers [1945] have obtained Z( -)-thyroxine in small yields (up to 4%); there is no reason to suppose that racemization ocours during the oxidation; indeed, the specific rotation of the thyroxine thus obtained was higher than that obtained either by resolution of the ¿ZZ-amino-acid [Harington, 1928] or by isolation from the thyroid gland by Foster et al. [1936] . This led to the hope that if d(~)-diiodotyrosine could be prepared in quantity, sufficient d( + )-thyroxine might be obtained to test its activity on cases of human myxoedema.
At the time when these experiments were planned, the resolution of cZZ-tyrosine by Sealock [1946] [Bergmann & Zervas, 1932] was converted into O-methyl-A-carbobenzyloxytyrosine by the action of dimethyl sulphate and excess of alkali ; catalytic reduction led to O-methyl-Z-tyrosine. The latter compound had already been prepared by Behr & Clarke [1932] by the methylation and subsequent hydrolysis of A-acetyl-Z-tyrosine, but this was not done under the conditions defined by Bergmann & Zervas [1928] under which tyrosine must be acetylated in order to avoid any racemization. Behr & Clarke did in fact obtain a partly racemized product after acetylation, and their O-methyl-Z-tyrosine did not have such a high specific rotation as that prepared in the present work where the conditions of acetylation are not conducive to racemization.
O-Methyl-Z-tyrosine was converted by the action of nitrosyl bromide into a-bromo-/S-(^-methoxy-phenyl) propionic acid; treatment of this acid with ammonia gave a good yield of O-methyl-d-tyrosine, but at this stage of the synthesis, some racemiza¬ tion did occur. It was not found possible to obtain O-methyl-d-tyrosine with as high a rotation as the O-methyl-Z-tyrosine, although a fairly optically pure product was obtained by conversion of the bromo-acid to the amino-acid at 0°. The ¿Z-tyrosine obtained by demethylation of this somewhat racemized O-methyl-cZ-tyrosine was easily obtained optically pure by one crystallization from water, since the racemate is more soluble than optically active tyrosine.
Iodination of cZ-tyrosine either by the method of Harington [1928] [Bergmann & Zervas, 1932] (12-4 g.) was dissolved in N-NaOH (88 ml.) and kept for 15 min. at room temperature. The solution was then treated alternately with 5N-NaOH (4 ml.) and dimethyl sulphate (2 ml.) with vigorous shaking; the additions were made four times in all, giving 100% excess of dimethyl sulphate.
At the end of the reaction the solution was acidified with dilute HC1; the oily precipitate solidified on scratching and was recrystallized from aqueous alcohol. It formed fine colourless needles; the yield was 90% of the theoretical; m.p. 112°. Found: N, 4-24%; C18H1905N requires N, 4-26%.
O-Methyl-l-tyrosine. The preceding compound (11-9 g.) was dissolved in 50 ml. of 60% alcohol and 7 ml. of 3N-HC1 and reduced catalytically in the presence of pal¬ ladium black (1 g.). At the end of the reduction, the solution was filtered and con¬ centrated under diminished pressure. On cooling, the solution deposited 5-5 g. of crystals (m.p. 237-8°d ecomp.) and by concentrating the mother liquor a second crop of 0-32 g. was obtained with the same melting-point. This is the hydrochloride ob¬ tained by ecomp.). The acid was obtained by dissolving the hydrochloride in water and neutralizing the hot solution with ammonia; it had m.p. 259-260°( decomp.) (a)f = + 10-0°in 2% solution in N-HC1. x-Bromo-ß-(p-methoxyphenyl) propionic acid. O-Methyl-Z-tyrosine (17-0 g.) was dissolved in 3N-sulphuric acid (145 ml.) and chilled in ice-salt. Potassium bromide (35 g.) was added and stirred till dissolved. Sodium nitrite Bergmann [1942] , who investigated the temperature coefficient of the specific rotation of Z-tyrosine. 
Clinical trials
The activity of Z-thyroxine has been assayed in two cases of myxoedema and that of cZ-thyroxine in four cases of myxoedema. The material was injected intravenously daily, sufficient thyroxine having been dissolved to last 1 or 3 days. The results are charted in Figs. 1 and 2 .
RESULTS
One patient, E.D. in Fig. 1 Fig. 2 , was of the same order of magnitude as the standard response to 0-5 mg. of iodine in the form of thyroxine polypeptide but at a higher level. The basal metabolism rose to + 12, and there was rapid improvement in the myxoedematous symptoms.
The second patient with myxoedema, C.J. in Fig. 1 , also failed to show any response to cZ-thyroxine in amounts containing 0-5 mg. of iodine for 9 days, but made a standard response to Z-thyroxine in a daily dose of 0-25 mg. of iodine (see Fig. 2) Fig. 1, a The fourth patient, L. T. in Fig. 1 The question whether the activity of the whole thyroid is due to its total iodine content or its thyroxine content has been debated for some time, and is not yet resolved. It is possible that the high activity of the whole gland is accounted for by the high activity of Z-thyroxine as compared with an equivalent amount of the dlamino-acid, but further work is required to settle this point.
